Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Colaneri M, Scaglione G, Fassio F, Galli L, Lai A, Bergna A, Gabrieli A, Tarkowski M, Ventura CD, Colombo V, Cordier L, Bernasconi D, Corbellino M, Dedivitiis G, Borghetti S, Visigalli D, Sollima S, Casalini G, Rizzardini G, Gori A, Antinori S, Riva A, Schiavini M. Colaneri M, et al. Among authors: visigalli d. Virol J. 2024 Mar 20;21(1):68. doi: 10.1186/s12985-024-02333-x. Virol J. 2024. PMID: 38509536 Free PMC article.
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
Massa F, Vigo T, Bellucci M, Giunti D, Emanuela MM, Visigalli D, Capodivento G, Cerne D, Assini A, Boni S, Rizzi D, Narciso E, Grisanti GS, Coco E, Uccelli A, Schenone A, Franciotta D, Benedetti L. Massa F, et al. Among authors: visigalli d. Neurol Sci. 2024 Mar;45(3):849-859. doi: 10.1007/s10072-023-07279-6. Epub 2024 Jan 3. Neurol Sci. 2024. PMID: 38169013
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
Bellucci M, Germano F, Grisanti S, Castellano C, Tazza F, Mobilia EM, Visigalli D, Novi G, Massa F, Rossi S, Durando P, Cabona C, Schenone A, Franciotta D, Benedetti L. Bellucci M, et al. Among authors: visigalli d. Front Immunol. 2022 Jul 18;13:894872. doi: 10.3389/fimmu.2022.894872. eCollection 2022. Front Immunol. 2022. PMID: 35924236 Free PMC article.
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS.
Capodivento G, De Michelis C, Carpo M, Fancellu R, Schirinzi E, Severi D, Visigalli D, Franciotta D, Manganelli F, Siciliano G, Beronio A, Capello E, Lanteri P, Nobile-Orazio E, Schenone A, Benedetti L, Nobbio L. Capodivento G, et al. Among authors: visigalli d. J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):303-310. doi: 10.1136/jnnp-2020-324445. Epub 2020 Oct 22. J Neurol Neurosurg Psychiatry. 2021. PMID: 33093191 Free PMC article.
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.
Capodivento G, Visigalli D, Garnero M, Fancellu R, Ferrara MD, Basit A, Hamid Z, Pastore VP, Garibaldi S, Armirotti A, Mancardi G, Serrati C, Capello E, Schenone A, Nobbio L. Capodivento G, et al. Among authors: visigalli d. Sci Rep. 2017 Aug 10;7(1):7831. doi: 10.1038/s41598-017-08314-1. Sci Rep. 2017. PMID: 28798317 Free PMC article.
15 results